ATE320602T1 - Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren - Google Patents

Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren

Info

Publication number
ATE320602T1
ATE320602T1 AT96926558T AT96926558T ATE320602T1 AT E320602 T1 ATE320602 T1 AT E320602T1 AT 96926558 T AT96926558 T AT 96926558T AT 96926558 T AT96926558 T AT 96926558T AT E320602 T1 ATE320602 T1 AT E320602T1
Authority
AT
Austria
Prior art keywords
level
tendence
metastasization
tumors
evaluation
Prior art date
Application number
AT96926558T
Other languages
English (en)
Inventor
Rachel Bar-Shavit
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Application granted granted Critical
Publication of ATE320602T1 publication Critical patent/ATE320602T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT96926558T 1995-08-10 1996-08-08 Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren ATE320602T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11489095A IL114890A (en) 1995-08-10 1995-08-10 Method and kits for evaluating the metastatic tendency of tumor cells

Publications (1)

Publication Number Publication Date
ATE320602T1 true ATE320602T1 (de) 2006-04-15

Family

ID=11067856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926558T ATE320602T1 (de) 1995-08-10 1996-08-08 Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren

Country Status (9)

Country Link
US (2) US6183954B1 (de)
EP (1) EP0846263B1 (de)
AT (1) ATE320602T1 (de)
AU (1) AU6667496A (de)
CA (1) CA2229108C (de)
DE (1) DE69635925T2 (de)
ES (1) ES2260771T3 (de)
IL (1) IL114890A (de)
WO (1) WO1997007387A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125698A (en) * 1998-08-07 2007-03-08 Hadasit Med Res Service Use of molecules associated with protease activated receptors for the preparation of pharmaceutical compositions and pharmaceutical compositions comprising them
AU5789500A (en) * 1999-07-09 2001-01-30 Burnham Institute, The A method for determining the prognosis of cancer patients by measuring levels ofbag expression
US7351530B1 (en) * 2001-12-20 2008-04-01 Health Research, Inc. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
US20060216290A1 (en) * 2003-03-11 2006-09-28 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (Par1)
JP2008501346A (ja) * 2004-06-04 2008-01-24 アビアラデックス，インコーポレイティド がんに関する遺伝子ｈｏｘｂ１３の重要性
EP2250508A1 (de) * 2008-02-07 2010-11-17 Hadasit Medical Research Services & Development Limited Immundetektion eines karzinösen zustandes bei einer person

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
US5516889A (en) * 1993-06-21 1996-05-14 University Technologies International, Inc. Synthetic thrombin receptor peptides

Also Published As

Publication number Publication date
WO1997007387A3 (en) 1997-05-22
ES2260771T3 (es) 2006-11-01
DE69635925T2 (de) 2007-01-25
CA2229108A1 (en) 1997-02-27
WO1997007387A2 (en) 1997-02-27
DE69635925D1 (de) 2006-05-11
US6395496B1 (en) 2002-05-28
EP0846263A4 (de) 2001-08-16
AU6667496A (en) 1997-03-12
IL114890A0 (en) 1995-12-08
EP0846263A2 (de) 1998-06-10
IL114890A (en) 1999-08-17
CA2229108C (en) 2008-12-09
EP0846263B1 (de) 2006-03-15
US6183954B1 (en) 2001-02-06

Similar Documents

Publication Publication Date Title
ATE224457T1 (de) Verfahren zur identifizierung von nukleinsäuren, welche agenzien kodieren, die zelluläre phenotypen beeinflussen
ATE530180T1 (de) Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen
ATE254931T1 (de) Mesothelinantigen, verfahren und testsatz zur targetierung
ATE278805T1 (de) Verfahren zur quantifizierung von cholesterol in lipoproteinen und quantifizierungsreagenzien
MY122167A (en) Method for charactering subsurface petrophysical properties using linear shape attributes
ATE445158T1 (de) Toxizitätstypisierung unter verwendung von leberstammzellen
ATE211506T1 (de) Ein verfahren zum nachweis biologisch aktiver substanzen
AP9901654A0 (en) Gene sequencer and methods.
WO1999024463A3 (en) Signal peptide-containing proteins
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
SE9604815D0 (sv) A metod of diagnosis
WO1999055913A3 (en) Reduced complexity nucleic acid targets and methods of using same
ATE320602T1 (de) Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren
DE69029113D1 (de) Verfahren zur Bestimmung von Allelen für zystische Fibrose
MXPA01006914A (es) Metodos para identificar combinaciones de entidades como terapeuticas.
WO2003033650A3 (en) Recombinant renilla reniformis system for bioluminescence resonance energy transfer
ATE490668T1 (de) Vorrichtung zur bestimmung der bei einem teilnehmersuchruf beteiligten basisstationssubsysteme und verfahren zum automatischen einrichten der vorrichtung
DE60126991D1 (de) Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
WO2001038581A3 (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
WO1994023059A3 (en) Anti-microbial agents and screening method therefor
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples
ATE274702T1 (de) Verwendung derivatisierter reagenzien in chemilumineszenz- und elektrochemilumineszenz- nachweisverfahren
DK0959132T3 (da) Nukleinsyre, der koder for receptortypeproteinkinase
ATE243320T1 (de) Diagnostische verfahren und zusammensetzungen auf basis der verteilung von rad51

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties